Improving prenatal care for at-risk patients using hybrid models developed during COVID-19.
Adapting COVID-19 Prenatal Care Innovations for Patients At Risk of Adverse Pregnancy Outcomes: a Mixed Methods Study of the Plan for Appropriate Tailored Healthcare in Pregnancy
This study is looking at how mixing in-person doctor visits with online check-ins can help pregnant people, especially those at higher risk, get better care and have a better experience during their pregnancy.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10906822 on NIH RePORTER |
What this research studies
This research investigates how hybrid prenatal care models, which combine in-person visits with telemedicine, can improve healthcare delivery for pregnant individuals, particularly those at risk of adverse outcomes. The study focuses on understanding the impact of these models on healthcare utilization, health outcomes, and experiences of both patients and providers. By evaluating the effectiveness of these innovative care approaches, the research aims to adapt them for broader implementation, especially for marginalized populations who may face barriers to traditional care.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant individuals who are considered average-risk but may belong to marginalized groups, such as low-income, Black, or rural populations.
Not a fit: Patients who are at high risk for pregnancy complications and require intensive monitoring and care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and effective prenatal care for patients at risk of complications during pregnancy.
How similar studies have performed: Other research has shown promise in using hybrid care models during the COVID-19 pandemic, indicating potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Peahl, Alex — University of Michigan at Ann Arbor
- Study coordinator: Peahl, Alex
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.